
Bal Pharma Stock Falls to 52-Week Low of Rs.73.61 Amidst Prolonged Downtrend
2025-12-04 12:43:48Bal Pharma's shares reached a fresh 52-week low of Rs.73.61 today, marking a continuation of the stock's downward trajectory over recent sessions. The pharmaceutical company’s stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial and operational metrics.
Read More
Bal Pharma Stock Falls to 52-Week Low of Rs.74 Amidst Prolonged Downtrend
2025-11-26 09:27:09Bal Pharma has reached a new 52-week low of Rs.74, marking a significant decline as the stock continues its downward trajectory over the past eight trading sessions.
Read More
Bal Pharma Stock Falls to 52-Week Low of Rs.74 Amidst Prolonged Downtrend
2025-11-26 09:27:07Bal Pharma has reached a new 52-week low of Rs.74, marking a significant decline as the stock continues its downward trajectory over the past eight trading sessions. This fresh low reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector and highlights the challenges faced by the company in recent periods.
Read More
Bal Pharma Stock Falls to 52-Week Low of Rs.74.2 Amidst Prolonged Downtrend
2025-11-25 15:40:01Bal Pharma has reached a new 52-week low of Rs.74.2 today, marking a significant decline amid a sustained downward trajectory over the past week. The stock’s performance contrasts sharply with broader market trends, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.
Read MoreWhy is Bal Pharma falling/rising?
2025-11-25 00:46:58Persistent Downward Momentum Bal Pharma’s recent price action reflects a challenging period for the company’s stock. Over the past week, the share price has fallen by 6.45%, significantly underperforming the Sensex, which remained almost flat with a marginal decline of 0.06%. The one-month performance further emphasises this weakness, with the stock declining by 10.59%, while the Sensex gained 0.82% during the same period. This divergence highlights the stock’s relative underperformance against the benchmark index. Year-to-date figures paint an even more concerning picture. Bal Pharma has lost 38.98% of its value, contrasting sharply with the Sensex’s robust 8.65% gain. Over the last twelve months, the stock’s decline deepens to 44.96%, while the Sensex has appreciated...
Read More
Bal Pharma Stock Falls to 52-Week Low of Rs.75 Amidst Prolonged Downtrend
2025-11-24 10:41:37Bal Pharma has reached a new 52-week low of Rs.75 today, marking a significant decline amid a sustained period of negative returns and underperformance relative to its sector and benchmark indices.
Read More
Bal Pharma Stock Falls to 52-Week Low of Rs.75 Amidst Prolonged Downtrend
2025-11-24 10:41:34Bal Pharma has reached a new 52-week low of Rs.75, marking a significant decline amid a sustained period of negative returns. The stock has been on a downward trajectory for six consecutive trading sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.
Read More
Bal Pharma Stock Falls to 52-Week Low of Rs.75 Amidst Prolonged Downtrend
2025-11-24 10:41:33Bal Pharma has reached a new 52-week low of Rs.75, marking a significant decline amid a sustained period of negative returns. The stock’s recent performance contrasts sharply with broader market gains, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.
Read More
Bal Pharma Stock Falls to 52-Week Low of Rs.75 Amidst Prolonged Downtrend
2025-11-24 10:41:33Bal Pharma has reached a new 52-week low of Rs.75, marking a significant decline amid a sustained period of negative returns. The stock has been trading below all key moving averages and continues to underperform its sector and benchmark indices.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
12-Jan-2026 | Source : BSEWe are submitting newspaper advertisements of the postal ballot notice issued by the Company on 08.01.2026 and published on 09.01.2026.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09-Jan-2026 | Source : BSEConfirmation as per Regulation 74(5) of SEBI(DP) Regulations for the quarter ended 31.12.2025.
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
08-Jan-2026 | Source : BSEPostal Ballot notice for appointment of Dr.Mukesh Beekamchand ( DIN # 11295580) as independent Director of the Company.
Corporate Actions
No Upcoming Board Meetings
Bal Pharma Ltd has declared 12% dividend, ex-date: 18 Sep 25
No Splits history available
No Bonus history available
No Rights history available